{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:03:37Z","timestamp":1792746217152,"version":"4.5.0"},"reference-count":194,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Polycystic ovary syndrome (PCOS) is a heterogeneous functional endocrine disorder associated with a low-grade, chronic inflammatory state. Patients with PCOS present an increased risk of metabolic comorbidities and often menstrual dysregulation and infertility due to anovulation and\/or poor oocyte quality. Multiple mechanisms including oxidative stress and low-grade inflammation are believed to be responsible for oocyte deterioration; however, the influence of nitric oxide (NO) insufficiency in oocyte quality and ovulatory dysfunction in PCOS is still a matter for debate. Higher production of superoxide (O\n                    <jats:sub>2<\/jats:sub>\n                    <jats:sup>\u2022\u2212<\/jats:sup>\n                    ) mediated DNA damage and impaired antioxidant defense have been implicated as contributory factors for the development of PCOS, with reported alteration in superoxide dismutase (SOD) function, an imbalanced zinc\/copper ratio, and increased catalase activity. These events may result in decreased hydrogen peroxide (H\n                    <jats:sub>2<\/jats:sub>\n                    O\n                    <jats:sub>2<\/jats:sub>\n                    ) accumulation with increased lipid peroxidation events. A decrease in NO, potentially due to increased activity of NO synthase (NOS) inhibitors such as asymmetric dimethylarginine (ADMA), and imbalance in the distribution of reactive oxygen species (ROS), such as decreased H\n                    <jats:sub>2<\/jats:sub>\n                    O\n                    <jats:sub>2<\/jats:sub>\n                    and increased O\n                    <jats:sub>2<\/jats:sub>\n                    <jats:sup>\u2022\u2212<\/jats:sup>\n                    , may offset the physiological processes surrounding follicular development, oocyte maturation, and ovulation contributing to the reproductive dysfunction in patients with PCOS. Thus, this proposal aims to evaluate the specific roles of NO, oxidative stress, ROS, and enzymatic and nonenzymatic elements in the pathogenesis of PCOS ovarian dysfunction, including oligo- anovulation and oocyte quality, with the intent to inspire better application of therapeutic options. The authors believe more consideration into the specific roles of oxidative stress, ROS, and enzymatic and nonenzymatic elements may allow for a more thorough understanding of PCOS. Future efforts elaborating on the role of NO in the preoptic nucleus to determine its influence on GnRH firing and follicle-stimulating hormone\/Luteinizing hormone (FSH\/LH) production with ovulation would be of benefit in PCOS. Consequently, treatment with an ADMA inhibitor or NO donor may prove beneficial to PCOS patients experiencing reproductive dysfunction and infertility.\n                  <\/jats:p>","DOI":"10.1186\/s12958-023-01159-6","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T01:01:50Z","timestamp":1700701310000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["A review of nitric oxide and oxidative stress in typical ovulatory women and in the pathogenesis of ovulatory dysfunction in PCOS"],"prefix":"10.1186","volume":"21","author":[{"given":"Awoniyi O.","family":"Awonuga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia G","family":"Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam M","family":"Abu-Soud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,23]]},"reference":[{"issue":"9","key":"1159_CR1","first-page":"3078","volume":"83","author":"ES Knochenhauer","year":"1998","unstructured":"Knochenhauer ES, et al. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab. 1998;83(9):3078\u201382.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"1159_CR2","first-page":"2434","volume":"85","author":"M Asuncion","year":"2000","unstructured":"Asuncion M, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected caucasian women from Spain. J Clin Endocrinol Metab. 2000;85(7):2434\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1159_CR3","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","volume":"36","author":"DA Dumesic","year":"2015","unstructured":"Dumesic DA, et al. Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome. Endocr Rev. 2015;36(5):487\u2013525.","journal-title":"Endocr Rev"},{"issue":"5","key":"1159_CR4","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/humupd\/dms019","volume":"18","author":"ECW Group","year":"2012","unstructured":"Group ECW. Health and fertility in World Health Organization group 2 anovulatory women. Hum Reprod Update. 2012;18(5):586\u201399.","journal-title":"Hum Reprod Update"},{"issue":"7414","key":"1159_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1136\/bmj.327.7414.546","volume":"327","author":"D Hamilton-Fairley","year":"2003","unstructured":"Hamilton-Fairley D, Taylor A. Anovulation BMJ. 2003;327(7414):546\u20139.","journal-title":"Anovulation BMJ"},{"issue":"6","key":"1159_CR6","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/ajo.13420","volume":"61","author":"J Parker","year":"2021","unstructured":"Parker J, O\u2019Brien C, Gersh FL. Developmental origins and transgenerational inheritance of polycystic ovary syndrome. Aust N Z J Obstet Gynaecol. 2021;61(6):922\u20136.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"1","key":"1159_CR7","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1933719116654992","volume":"24","author":"M Hewlett","year":"2017","unstructured":"Hewlett M, et al. Prenatal exposure to endocrine disruptors: a developmental etiology for polycystic ovary syndrome. Reprod Sci. 2017;24(1):19\u201327.","journal-title":"Reprod Sci"},{"issue":"2","key":"1159_CR8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/17446651.2019.1576522","volume":"14","author":"DH Abbott","year":"2019","unstructured":"Abbott DH, Dumesic DA, Levine JE. Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy. Expert Rev Endocrinol Metab. 2019;14(2):131\u201343.","journal-title":"Expert Rev Endocrinol Metab"},{"key":"1159_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000494899","volume":"53","author":"DH Abbott","year":"2019","unstructured":"Abbott DH, et al. In utero androgen excess: a developmental commonality preceding polycystic ovary syndrome? Front Horm Res. 2019;53:1\u201317.","journal-title":"Front Horm Res"},{"key":"1159_CR10","doi-asserted-by":"crossref","unstructured":"Stener-Victorin E et al. Animal models to understand the etiology and pathophysiology of polycystic ovary syndrome. Endocr Rev, 2020. 41(4).","DOI":"10.1210\/endrev\/bnaa010"},{"issue":"10","key":"1159_CR11","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s10815-021-02241-x","volume":"38","author":"A Naigaonkar","year":"2021","unstructured":"Naigaonkar A, et al. Altered redox status may contribute to aberrant folliculogenesis and poor reproductive outcomes in women with polycystic ovary syndrome. J Assist Reprod Genet. 2021;38(10):2609\u201323.","journal-title":"J Assist Reprod Genet"},{"key":"1159_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.4103\/ijpvm.IJPVM_576_17","volume":"10","author":"M Mohammadi","year":"2019","unstructured":"Mohammadi M. Oxidative stress and polycystic ovary syndrome: a brief review. Int J Prev Med. 2019;10:86.","journal-title":"Int J Prev Med"},{"issue":"4","key":"1159_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S0026-0495(99)90100-2","volume":"48","author":"F Gonzalez","year":"1999","unstructured":"Gonzalez F, et al. Elevated serum levels of Tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome. Metabolism. 1999;48(4):437\u201341.","journal-title":"Metabolism"},{"issue":"2","key":"1159_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1055\/s-0029-1212086","volume":"107","author":"GS Hotamisligil","year":"1999","unstructured":"Hotamisligil GS. Mechanisms of TNF-alpha-induced insulin resistance. Exp Clin Endocrinol Diabetes. 1999;107(2):119\u201325.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"1","key":"1159_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1080\/09513590.2021.2003326","volume":"38","author":"JL Hern\u00e1ndez-Jim\u00e9nez","year":"2022","unstructured":"Hern\u00e1ndez-Jim\u00e9nez JL, et al. Polycystic ovarian syndrome: signs and feedback effects of hyperandrogenism and insulin resistance. Gynecol Endocrinol. 2022;38(1):2\u20139.","journal-title":"Gynecol Endocrinol"},{"key":"1159_CR16","doi-asserted-by":"crossref","unstructured":"Dabravolski SA et al. Mitochondrial dysfunction and chronic inflammation in polycystic ovary syndrome. Int J Mol Sci, 2021. 22(8).","DOI":"10.3390\/ijms22083923"},{"key":"1159_CR17","doi-asserted-by":"crossref","unstructured":"Zeber-Lubecka N, Ciebiera M, Hennig EE. Polycystic ovary syndrome and oxidative stress-from bench to Bedside. Int J Mol Sci, 2023. 24(18).","DOI":"10.3390\/ijms241814126"},{"issue":"7","key":"1159_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","volume":"21","author":"H Sies","year":"2020","unstructured":"Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020;21(7):363\u201383.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1159_CR19","doi-asserted-by":"crossref","unstructured":"Chiorcea-Paquim AM. 8-oxoguanine and 8-oxodeoxyguanosine biomarkers of oxidative DNA damage: a review on HPLC-ECD determination. Molecules, 2022. 27(5).","DOI":"10.3390\/molecules27051620"},{"issue":"7","key":"1159_CR20","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1016\/j.fertnstert.2010.03.049","volume":"94","author":"H Sova","year":"2010","unstructured":"Sova H, et al. Distinctively low levels of serum 8-hydroxydeoxyguanosine in women with polycystic ovary syndrome. Fertil Steril. 2010;94(7):2670\u20133.","journal-title":"Fertil Steril"},{"issue":"6","key":"1159_CR21","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1210\/jcem.86.6.7580","volume":"86","author":"CC Kelly","year":"2001","unstructured":"Kelly CC, et al. Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab. 2001;86(6):2453\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"1159_CR22","doi-asserted-by":"crossref","unstructured":"Mouanness M et al. Contribution of Advanced Glycation End products to PCOS Key Elements: a narrative review. Nutrients, 2022. 14(17).","DOI":"10.3390\/nu14173578"},{"issue":"5","key":"1159_CR23","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5468\/ogs.2019.62.5.335","volume":"62","author":"CI Enechukwu","year":"2019","unstructured":"Enechukwu CI, et al. Oxidative stress markers and lipid profiles of patients with polycystic ovary syndrome in a Nigerian tertiary hospital. Obstet Gynecol Sci. 2019;62(5):335\u201343.","journal-title":"Obstet Gynecol Sci"},{"issue":"6","key":"1159_CR24","doi-asserted-by":"publisher","first-page":"F145","DOI":"10.1530\/REP-22-0152","volume":"164","author":"E Rudnicka","year":"2022","unstructured":"Rudnicka E, et al. OXIDATIVE STRESS AND REPRODUCTIVE FUNCTION: oxidative stress in polycystic ovary syndrome. Reproduction. 2022;164(6):F145\u2013f154.","journal-title":"Reproduction"},{"key":"1159_CR25","doi-asserted-by":"publisher","first-page":"1018674","DOI":"10.3389\/fnut.2022.1018674","volume":"9","author":"W Li","year":"2022","unstructured":"Li W, et al. Oxidative stress and antioxidant imbalance in ovulation disorder in patients with polycystic ovary syndrome. Front Nutr. 2022;9:1018674.","journal-title":"Front Nutr"},{"issue":"2","key":"1159_CR26","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","volume":"91","author":"R Azziz","year":"2009","unstructured":"Azziz R, et al. The androgen excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91(2):456\u201388.","journal-title":"Fertil Steril"},{"issue":"4","key":"1159_CR27","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.fertnstert.2022.07.009","volume":"118","author":"MG Munro","year":"2022","unstructured":"Munro MG, et al. The FIGO Ovulatory disorders classification system. Fertil Steril. 2022;118(4):768\u201386.","journal-title":"Fertil Steril"},{"issue":"11","key":"1159_CR28","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","volume":"39","author":"S Siddiqui","year":"2022","unstructured":"Siddiqui S, et al. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet. 2022;39(11):2439\u201373.","journal-title":"J Assist Reprod Genet"},{"key":"1159_CR29","doi-asserted-by":"publisher","first-page":"108989","DOI":"10.1016\/j.steroids.2022.108989","volume":"180","author":"NR Chappell","year":"2022","unstructured":"Chappell NR, Gibbons WE, Blesson CS. Pathology of hyperandrogenemia in the oocyte of polycystic ovary syndrome. Steroids. 2022;180:108989.","journal-title":"Steroids"},{"key":"1159_CR30","doi-asserted-by":"publisher","first-page":"815968","DOI":"10.3389\/fendo.2022.815968","volume":"13","author":"B Liao","year":"2022","unstructured":"Liao B, et al. Effects of Androgen excess-related metabolic disturbances on Granulosa cell function and Follicular Development. Front Endocrinol (Lausanne). 2022;13:815968.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1159_CR31","doi-asserted-by":"crossref","unstructured":"Immediata V et al. Oxidative Stress and Human Ovarian Response-From Somatic Ovarian Cells to Oocytes Damage: A Clinical Comprehensive Narrative Review Antioxidants (Basel), 2022. 11(7).","DOI":"10.3390\/antiox11071335"},{"key":"1159_CR32","doi-asserted-by":"crossref","unstructured":"Chappel S. The role of mitochondria from mature oocyte to viable blastocyst Obstet Gynecol Int, 2013. 2013: p.\u00a0183024.","DOI":"10.1155\/2013\/183024"},{"issue":"7","key":"1159_CR33","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1631\/jzus.B0820379","volume":"10","author":"LY Wang","year":"2009","unstructured":"Wang LY, et al. Mitochondrial functions on oocytes and preimplantation embryos. J Zhejiang Univ Sci B. 2009;10(7):483\u201392.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"4","key":"1159_CR34","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/1933719115607993","volume":"23","author":"F Shaeib","year":"2016","unstructured":"Shaeib F, et al. The Defensive Role of Cumulus Cells against Reactive Oxygen Species Insult in metaphase II mouse oocytes. Reprod Sci. 2016;23(4):498\u2013507.","journal-title":"Reprod Sci"},{"issue":"2","key":"1159_CR35","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.fertnstert.2013.04.030","volume":"100","author":"J Banerjee","year":"2013","unstructured":"Banerjee J, et al. Peroxynitrite affects the cumulus cell defense of metaphase II mouse oocytes leading to disruption of the spindle structure in vitro. Fertil Steril. 2013;100(2):578\u2013584e1.","journal-title":"Fertil Steril"},{"issue":"9","key":"1159_CR36","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1172\/JCI120843","volume":"128","author":"GN Ruegsegger","year":"2018","unstructured":"Ruegsegger GN, et al. Altered mitochondrial function in insulin-deficient and insulin-resistant states. J Clin Invest. 2018;128(9):3671\u201381.","journal-title":"J Clin Invest"},{"issue":"4","key":"1159_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/CIRCRESAHA.107.165472","volume":"102","author":"JA Kim","year":"2008","unstructured":"Kim JA, Wei Y, Sowers JR. Role of mitochondrial dysfunction in insulin resistance. Circ Res. 2008;102(4):401\u201314.","journal-title":"Circ Res"},{"key":"1159_CR38","doi-asserted-by":"crossref","unstructured":"Lewis MT et al. Quantification of mitochondrial oxidative phosphorylation in metabolic Disease: application to type 2 Diabetes. Int J Mol Sci, 2019. 20(21).","DOI":"10.3390\/ijms20215271"},{"issue":"3","key":"1159_CR39","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5152\/eurasianjmed.2018.17397","volume":"50","author":"SK Bardaweel","year":"2018","unstructured":"Bardaweel SK, et al. Reactive oxygen species: the dual role in physiological and pathological conditions of the human body. Eurasian J Med. 2018;50(3):193\u2013201.","journal-title":"Eurasian J Med"},{"issue":"2","key":"1159_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1134\/S000629791002001X","volume":"75","author":"DS Izyumov","year":"2010","unstructured":"Izyumov DS, et al. Mitochondria as source of reactive oxygen species under oxidative stress. Study with novel mitochondria-targeted antioxidants\u2013the Skulachev-ion derivatives. Biochem (Mosc). 2010;75(2):123\u20139.","journal-title":"Biochem (Mosc)"},{"issue":"2","key":"1159_CR41","doi-asserted-by":"publisher","first-page":"G228","DOI":"10.1152\/ajpgi.00465.2011","volume":"303","author":"FJ Cubero","year":"2012","unstructured":"Cubero FJ, Nieto N. Arachidonic acid stimulates TNF\u03b1 production in Kupffer cells via a reactive oxygen species-pERK1\/2-Egr1-dependent mechanism. Am J Physiol Gastrointest Liver Physiol. 2012;303(2):G228\u201339.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"10","key":"1159_CR42","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1161\/CIRCRESAHA.111.243972","volume":"110","author":"B Lass\u00e8gue","year":"2012","unstructured":"Lass\u00e8gue B, San A, Mart\u00edn, Griendling KK. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res. 2012;110(10):1364\u201390.","journal-title":"Circ Res"},{"key":"1159_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.niox.2022.04.006","volume":"124","author":"OG Camp","year":"2022","unstructured":"Camp OG, et al. Hypochlorous acid facilitates inducible nitric oxide synthase subunit dissociation: the link between heme destruction, disturbance of the zinc-tetrathiolate center, and the prevention by melatonin. Nitric Oxide. 2022;124:32\u20138.","journal-title":"Nitric Oxide"},{"issue":"1","key":"1159_CR44","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1152\/physrev.00029.2006","volume":"87","author":"P Pacher","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and Disease. Physiol Rev. 2007;87(1):315\u2013424.","journal-title":"Physiol Rev"},{"issue":"2","key":"1159_CR45","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2174\/092986711794088317","volume":"18","author":"K Stadler","year":"2011","unstructured":"Stadler K. Peroxynitrite-driven mechanisms in Diabetes and insulin resistance - the latest advances. Curr Med Chem. 2011;18(2):280\u201390.","journal-title":"Curr Med Chem"},{"issue":"1","key":"1159_CR46","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/REP-14-0524","volume":"150","author":"G Basini","year":"2015","unstructured":"Basini G, Grasselli F. Nitric oxide in follicle development and oocyte competence. Reproduction. 2015;150(1):R1\u20139.","journal-title":"Reproduction"},{"issue":"34","key":"1159_CR47","doi-asserted-by":"publisher","first-page":"11361","DOI":"10.1021\/bi050711f","volume":"44","author":"AP Goud","year":"2005","unstructured":"Goud AP, et al. Nitric oxide delays oocyte aging. Biochemistry. 2005;44(34):11361\u20138.","journal-title":"Biochemistry"},{"issue":"4","key":"1159_CR48","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/(SICI)1098-2795(200004)55:4<412::AID-MRD9>3.0.CO;2-W","volume":"55","author":"A Jablonka-Shariff","year":"2000","unstructured":"Jablonka-Shariff A, Olson LM. Nitric oxide is essential for optimal meiotic maturation of murine cumulus-oocyte complexes in vitro. Mol Reprod Dev. 2000;55(4):412\u201321.","journal-title":"Mol Reprod Dev"},{"issue":"5","key":"1159_CR49","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1095\/biolreprod.102.005264","volume":"67","author":"Y Nakamura","year":"2002","unstructured":"Nakamura Y, et al. Nitric oxide inhibits oocyte meiotic maturation. Biol Reprod. 2002;67(5):1588\u201392.","journal-title":"Biol Reprod"},{"key":"1159_CR50","doi-asserted-by":"crossref","unstructured":"Li J et al. Nitric oxide synthase is involved in Follicular Development via the PI3K\/AKT\/FoxO3a pathway in neonatal and immature rats. Anim (Basel), 2020. 10(2).","DOI":"10.3390\/ani10020248"},{"issue":"5","key":"1159_CR51","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1159\/000484107","volume":"43","author":"MB Krishna","year":"2017","unstructured":"Krishna MB, et al. Impaired arginine metabolism coupled to a defective Redox Conduit contributes to low plasma nitric oxide in polycystic ovary syndrome. Cell Physiol Biochem. 2017;43(5):1880\u201392.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"1159_CR52","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1210\/endo.140.2.6484","volume":"140","author":"V Prevot","year":"1999","unstructured":"Prevot V, et al. Estradiol coupling to endothelial nitric oxide stimulates gonadotropin-releasing hormone release from rat median eminence via a membrane receptor. Endocrinology. 1999;140(2):652\u20139.","journal-title":"Endocrinology"},{"issue":"4","key":"1159_CR53","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1055\/s-2002-36706","volume":"20","author":"CR McCartney","year":"2002","unstructured":"McCartney CR, Eagleson CA, Marshall JC. Regulation of gonadotropin secretion: implications for polycystic ovary syndrome. Semin Reprod Med. 2002;20(4):317\u201326.","journal-title":"Semin Reprod Med"},{"issue":"2","key":"1159_CR54","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0168-0102(02)00025-1","volume":"43","author":"T Ishihara","year":"2002","unstructured":"Ishihara T, et al. Sex difference in the expression and regulation of nitric oxide synthase gene in the rat preoptic area. Neurosci Res. 2002;43(2):147\u201354.","journal-title":"Neurosci Res"},{"issue":"7124","key":"1159_CR55","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nature05453","volume":"445","author":"ES Lein","year":"2007","unstructured":"Lein ES, et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature. 2007;445(7124):168\u201376.","journal-title":"Nature"},{"key":"1159_CR56","doi-asserted-by":"crossref","unstructured":"McCosh RB et al. Evidence that nitric oxide is critical for LH Surge Generation in Female Sheep. Endocrinology, 2020. 161(3).","DOI":"10.1210\/endocr\/bqaa010"},{"issue":"18","key":"1159_CR57","doi-asserted-by":"publisher","first-page":"8462","DOI":"10.1073\/pnas.89.18.8462","volume":"89","author":"LZ Krsmanovi\u0107","year":"1992","unstructured":"Krsmanovi\u0107 LZ, et al. Calcium signaling and episodic secretion of gonadotropin-releasing hormone in hypothalamic neurons. Proc Natl Acad Sci U S A. 1992;89(18):8462\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1159_CR58","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1210\/mend.15.3.0610","volume":"15","author":"LZ Krsmanovic","year":"2001","unstructured":"Krsmanovic LZ, et al. Regulation of Ca2+-sensitive adenylyl cyclase in gonadotropin-releasing hormone neurons. Mol Endocrinol. 2001;15(3):429\u201340.","journal-title":"Mol Endocrinol"},{"issue":"2","key":"1159_CR59","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1095\/biolreprod.112.105601","volume":"88","author":"H Kanasaki","year":"2013","unstructured":"Kanasaki H, Purwana IN, Miyazaki K. Possible role of PACAP and its PAC1 receptor in the differential regulation of pituitary LHbeta- and FSHbeta-subunit gene expression by pulsatile GnRH stimulation. Biol Reprod. 2013;88(2):35.","journal-title":"Biol Reprod"},{"key":"1159_CR60","unstructured":"Holesh JE, Bass AN, Lord M. Physiology, Ovulation, in StatPearls. 2023, StatPearls Publishing Copyright \u00a9 2023, StatPearls Publishing LLC.: Treasure Island (FL)."},{"issue":"12","key":"1159_CR61","first-page":"4179","volume":"82","author":"TL Daniels","year":"1997","unstructured":"Daniels TL, Berga SL. Resistance of gonadotropin releasing hormone drive to sex steroid-induced suppression in hyperandrogenic anovulation. J Clin Endocrinol Metab. 1997;82(12):4179\u201383.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1159_CR62","first-page":"582","volume":"83","author":"CL Pastor","year":"1998","unstructured":"Pastor CL, et al. Polycystic ovary syndrome: evidence for reduced sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab. 1998;83(2):582\u201390.","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"1159_CR63","first-page":"4047","volume":"85","author":"CA Eagleson","year":"2000","unstructured":"Eagleson CA, et al. Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone. J Clin Endocrinol Metab. 2000;85(11):4047\u201352.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"1159_CR64","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/S0014-2999(98)00274-X","volume":"351","author":"B Br\u00fcne","year":"1998","unstructured":"Br\u00fcne B, von Knethen A, Sandau KB. Nitric oxide and its role in apoptosis. Eur J Pharmacol. 1998;351(3):261\u201372.","journal-title":"Eur J Pharmacol"},{"key":"1159_CR65","doi-asserted-by":"publisher","first-page":"110499","DOI":"10.1016\/j.cellsig.2022.110499","volume":"101","author":"T Takahashi","year":"2023","unstructured":"Takahashi T, Ogiwara K. cAMP signaling in ovarian physiology in teleosts: a review. Cell Signal. 2023;101:110499.","journal-title":"Cell Signal"},{"issue":"4","key":"1159_CR66","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1073\/pnas.1017213108","volume":"108","author":"K Shkolnik","year":"2011","unstructured":"Shkolnik K, et al. Reactive oxygen species are indispensable in ovulation. Proc Natl Acad Sci U S A. 2011;108(4):1462\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1159_CR67","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1210\/en.2018-00485","volume":"159","author":"RL Robker","year":"2018","unstructured":"Robker RL, Hennebold JD, Russell DL. Coordination of Ovulation and Oocyte Maturation: a good egg at the right time. Endocrinology. 2018;159(9):3209\u201318.","journal-title":"Endocrinology"},{"issue":"3","key":"1159_CR68","first-page":"527","volume":"104","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Huang L, Brayboy L. Macrophages: An Indispensable Piece of Ovarian Health Biol Reprod. 2021;104(3):527\u201338.","journal-title":"Macrophages: An Indispensable Piece of Ovarian Health Biol Reprod"},{"issue":"2","key":"1159_CR69","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/humupd\/dmh011","volume":"10","author":"R Wu","year":"2004","unstructured":"Wu R, et al. Macrophage contributions to ovarian function. Hum Reprod Update. 2004;10(2):119\u201333.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"1159_CR70","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/0974-1208.82351","volume":"4","author":"P Kumar","year":"2011","unstructured":"Kumar P, Sait SF. Luteinizing hormone and its dilemma in ovulation induction. J Hum Reprod Sci. 2011;4(1):2\u20137.","journal-title":"J Hum Reprod Sci"},{"key":"1159_CR71","doi-asserted-by":"crossref","unstructured":"Esparza LA et al. Hyperactive LH pulses and elevated kisspeptin and NKB gene expression in the Arcuate Nucleus of a PCOS Mouse Model. Endocrinology, 2020. 161(4).","DOI":"10.1210\/endocr\/bqaa018"},{"issue":"2","key":"1159_CR72","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s10815-020-02019-7","volume":"38","author":"Y Luo","year":"2021","unstructured":"Luo Y, et al. The role of miRNAs in polycystic ovary syndrome with insulin resistance. J Assist Reprod Genet. 2021;38(2):289\u2013304.","journal-title":"J Assist Reprod Genet"},{"issue":"9","key":"1159_CR73","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1007\/s43032-020-00375-4","volume":"28","author":"T Castillo-Higuera","year":"2021","unstructured":"Castillo-Higuera T, et al. A comprehensive overview of common polymorphic variants in genes related to polycystic ovary syndrome. Reprod Sci. 2021;28(9):2399\u2013412.","journal-title":"Reprod Sci"},{"issue":"1","key":"1159_CR74","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ecl.2020.10.006","volume":"50","author":"CK Welt","year":"2021","unstructured":"Welt CK. Genetics of Polycystic Ovary Syndrome: what is New? Endocrinol Metab Clin North Am. 2021;50(1):71\u201382.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"1159_CR75","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12902-022-01224-y","volume":"22","author":"A Mansour","year":"2022","unstructured":"Mansour A, et al. Ovarian volume, not follicle count, is independently associated with androgens in patients with polycystic ovary syndrome. BMC Endocr Disord. 2022;22(1):298.","journal-title":"BMC Endocr Disord"},{"issue":"3","key":"1159_CR76","first-page":"264","volume":"107","author":"T Williams","year":"2023","unstructured":"Williams T, Moore JB, Regehr J. Polycystic ovary syndrome: common questions and answers. Am Fam Physician. 2023;107(3):264\u201372.","journal-title":"Am Fam Physician"},{"issue":"5","key":"1159_CR77","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/er.2015-1104","volume":"37","author":"RL Rosenfield","year":"2016","unstructured":"Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467\u2013520.","journal-title":"Endocr Rev"},{"issue":"1","key":"1159_CR78","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1210\/jcem-52-1-156","volume":"52","author":"RA Lobo","year":"1981","unstructured":"Lobo RA, et al. Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO. J Clin Endocrinol Metab. 1981;52(1):156\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1159_CR79","first-page":"142","volume":"8","author":"R Dumitrescu","year":"2015","unstructured":"Dumitrescu R, et al. The polycystic ovary syndrome: an update on metabolic and hormonal mechanisms. J Med Life. 2015;8(2):142\u20135.","journal-title":"J Med Life"},{"issue":"4","key":"1159_CR80","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/0002-9378(75)90081-2","volume":"121","author":"GW DeVane","year":"1975","unstructured":"DeVane GW, et al. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian Disease. Am J Obstet Gynecol. 1975;121(4):496\u2013500.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"1159_CR81","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00041433-199912000-00002","volume":"10","author":"P Tontonoz","year":"1999","unstructured":"Tontonoz P, Nagy L. Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for Cardiovascular Disease. Curr Opin Lipidol. 1999;10(6):485\u201390.","journal-title":"Curr Opin Lipidol"},{"issue":"8","key":"1159_CR82","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1043-2760(02)00668-9","volume":"13","author":"CH Lee","year":"2002","unstructured":"Lee CH, Evans RM. Peroxisome proliferator-activated receptor-gamma in macrophage lipid homeostasis. Trends Endocrinol Metab. 2002;13(8):331\u20135.","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"1159_CR83","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/HUMREP\/10.6.1352","volume":"10","author":"M Jasper","year":"1995","unstructured":"Jasper M, Norman RJ. Immunoactive interleukin-1 beta and tumour necrosis factor-alpha in thecal, stromal and granulosa cell cultures from normal and polycystic ovaries. Hum Reprod. 1995;10(6):1352\u20134.","journal-title":"Hum Reprod"},{"issue":"3","key":"1159_CR84","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/S0015-0282(16)54891-2","volume":"57","author":"M Zolti","year":"1992","unstructured":"Zolti M, et al. Cytokine levels in follicular fluid of polycystic ovaries in patients treated with dexamethasone. Fertil Steril. 1992;57(3):501\u20134.","journal-title":"Fertil Steril"},{"issue":"2","key":"1159_CR85","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.8755-8920.2000.440203.x","volume":"44","author":"RR Deshpande","year":"2000","unstructured":"Deshpande RR, et al. Alteration of cytokine production in follicular cystic ovaries induced in mice by neonatal estradiol injection. Am J Reprod Immunol. 2000;44(2):80\u20138.","journal-title":"Am J Reprod Immunol"},{"issue":"6","key":"1159_CR86","first-page":"1177","volume":"101","author":"G Amato","year":"2003","unstructured":"Amato G, et al. Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles. Obstet Gynecol. 2003;101(6):1177\u201382.","journal-title":"Obstet Gynecol"},{"issue":"2\u20133","key":"1159_CR87","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jsbmb.2009.12.015","volume":"120","author":"SC Gilliver","year":"2010","unstructured":"Gilliver SC. Sex steroids as inflammatory regulators. J Steroid Biochem Mol Biol. 2010;120(2\u20133):105\u201315.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1159_CR88","doi-asserted-by":"crossref","unstructured":"Rudnicka E et al. Chronic low Grade inflammation in Pathogenesis of PCOS. Int J Mol Sci, 2021. 22(7).","DOI":"10.3390\/ijms22073789"},{"issue":"10","key":"1159_CR89","doi-asserted-by":"publisher","first-page":"4649","DOI":"10.1210\/jc.2002-021688","volume":"88","author":"L Morin-Papunen","year":"2003","unstructured":"Morin-Papunen L, et al. Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003;88(10):4649\u201354.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"1159_CR90","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.steroids.2008.01.017","volume":"73","author":"C Stocco","year":"2008","unstructured":"Stocco C. Aromatase expression in the ovary: hormonal and molecular regulation. Steroids. 2008;73(5):473\u201387.","journal-title":"Steroids"},{"issue":"1","key":"1159_CR91","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0960-0760(96)00008-8","volume":"58","author":"GD Snyder","year":"1996","unstructured":"Snyder GD, et al. Nitric oxide inhibits aromatase activity: mechanisms of action. J Steroid Biochem Mol Biol. 1996;58(1):63\u20139.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"4","key":"1159_CR92","doi-asserted-by":"publisher","first-page":"227","DOI":"10.4103\/0974-1208.126285","volume":"6","author":"GA Raju","year":"2013","unstructured":"Raju GA, et al. Luteinizing hormone and follicle stimulating hormone synergy: a review of role in controlled ovarian hyper-stimulation. J Hum Reprod Sci. 2013;6(4):227\u201334.","journal-title":"J Hum Reprod Sci"},{"issue":"1\u20135","key":"1159_CR93","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jsbmb.2007.05.025","volume":"106","author":"RF Casper","year":"2007","unstructured":"Casper RF. Aromatase inhibitors in ovarian stimulation. J Steroid Biochem Mol Biol. 2007;106(1\u20135):71\u20135.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"1159_CR94","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1210\/endo.133.6.8243268","volume":"133","author":"JJ Bonavera","year":"1993","unstructured":"Bonavera JJ, et al. Evidence that nitric oxide may mediate the ovarian steroid-induced luteinizing hormone surge: involvement of excitatory amino acids. Endocrinology. 1993;133(6):2481\u20137.","journal-title":"Endocrinology"},{"issue":"5","key":"1159_CR95","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1210\/endo.137.5.8612536","volume":"137","author":"JJ Bonavera","year":"1996","unstructured":"Bonavera JJ, Kalra PS, Kalra SP. L-arginine\/nitric oxide amplifies the magnitude and duration of the luteinizing hormone surge induced by estrogen: involvement of neuropeptide Y. Endocrinology. 1996;137(5):1956\u201362.","journal-title":"Endocrinology"},{"issue":"4","key":"1159_CR96","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1530\/rep.1.00472","volume":"129","author":"JM Russell","year":"2005","unstructured":"Russell JM, et al. Effect of steroids and nitric oxide on pituitary hormone release in ovariectomized, peripubertal rats. Reproduction. 2005;129(4):497\u2013504.","journal-title":"Reproduction"},{"issue":"2","key":"1159_CR97","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1095\/biolreprod54.2.436","volume":"54","author":"N Bonello","year":"1996","unstructured":"Bonello N, et al. Inhibition of nitric oxide: effects on interleukin-1 beta-enhanced ovulation rate, steroid hormones, and ovarian leukocyte distribution at ovulation in the rat. Biol Reprod. 1996;54(2):436\u201345.","journal-title":"Biol Reprod"},{"key":"1159_CR98","doi-asserted-by":"publisher","first-page":"752410","DOI":"10.3389\/fendo.2021.752410","volume":"12","author":"Y Luo","year":"2021","unstructured":"Luo Y, et al. Roles of nitric oxide in the Regulation of Reproduction: a review. Front Endocrinol (Lausanne). 2021;12:752410.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"1159_CR99","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1210\/endo.135.5.7525265","volume":"135","author":"L Shukovski","year":"1994","unstructured":"Shukovski L, Tsafriri A. The involvement of nitric oxide in the ovulatory process in the rat. Endocrinology. 1994;135(5):2287\u201390.","journal-title":"Endocrinology"},{"issue":"5","key":"1159_CR100","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1378\/chest.09-0604","volume":"136","author":"PJ Mandhane","year":"2009","unstructured":"Mandhane PJ, et al. Changes in exhaled nitric oxide related to estrogen and progesterone during the menstrual cycle. Chest. 2009;136(5):1301\u20137.","journal-title":"Chest"},{"issue":"6","key":"1159_CR101","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/S0015-0282(16)58706-8","volume":"66","author":"E Cicinelli","year":"1996","unstructured":"Cicinelli E, et al. Circulating levels of nitric oxide in fertile women in relation to the menstrual cycle. Fertil Steril. 1996;66(6):1036\u20138.","journal-title":"Fertil Steril"},{"issue":"2","key":"1159_CR102","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0015-0282(97)00478-0","volume":"69","author":"H Ota","year":"1998","unstructured":"Ota H, et al. Endothelial nitric oxide synthase in the endometrium during the menstrual cycle in patients with endometriosis and adenomyosis. Fertil Steril. 1998;69(2):303\u20138.","journal-title":"Fertil Steril"},{"issue":"1","key":"1159_CR103","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.fertnstert.2013.08.056","volume":"101","author":"RS Legro","year":"2014","unstructured":"Legro RS, et al. The pregnancy in polycystic ovary syndrome II study: baseline characteristics and effects of obesity from a multicenter randomized clinical trial. Fertil Steril. 2014;101(1):258\u2013269e8.","journal-title":"Fertil Steril"},{"key":"1159_CR104","doi-asserted-by":"crossref","unstructured":"Winterbourn CC. Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol Lett, 1995. 82\u20133: p. 969 \u2013 74.","DOI":"10.1016\/0378-4274(95)03532-X"},{"issue":"4","key":"1159_CR105","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1095\/biolreprod60.4.959","volume":"60","author":"RC Dunnam","year":"1999","unstructured":"Dunnam RC, et al. Ovarian hormone secretory response to gonadotropins and nitric oxide following chronic nitric oxide deficiency in the rat. Biol Reprod. 1999;60(4):959\u201363.","journal-title":"Biol Reprod"},{"issue":"6","key":"1159_CR106","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/0092-8674(94)90266-6","volume":"78","author":"C Nathan","year":"1994","unstructured":"Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell. 1994;78(6):915\u20138.","journal-title":"Cell"},{"issue":"30","key":"1159_CR107","doi-asserted-by":"publisher","first-page":"21276","DOI":"10.1074\/jbc.274.30.21276","volume":"274","author":"H Li","year":"1999","unstructured":"Li H, et al. Crystal structures of zinc-free and -bound heme domain of human inducible nitric-oxide synthase. Implications for dimer stability and comparison with endothelial nitric-oxide synthase. J Biol Chem. 1999;274(30):21276\u201384.","journal-title":"J Biol Chem"},{"key":"1159_CR108","doi-asserted-by":"publisher","first-page":"100937","DOI":"10.1016\/j.molmet.2020.01.001","volume":"35","author":"MA Sanchez-Garrido","year":"2020","unstructured":"Sanchez-Garrido MA, Tena-Sempere M. Metabolic dysfunction in polycystic ovary syndrome: pathogenic role of androgen excess and potential therapeutic strategies. Mol Metab. 2020;35:100937.","journal-title":"Mol Metab"},{"key":"1159_CR109","doi-asserted-by":"crossref","unstructured":"Schmalbrock LJ et al. Pronounced Trace element variation in follicular fluids of Subfertile Women undergoing assisted Reproduction. Nutrients, 2021. 13(11).","DOI":"10.3390\/nu13114134"},{"issue":"3","key":"1159_CR110","doi-asserted-by":"publisher","first-page":"270","DOI":"10.29252\/rbmb.9.3.270","volume":"9","author":"A Shenta","year":"2020","unstructured":"Shenta A, Saud K, Al-Shawi A. Assessment the correlations of hormones, lipid profiles, oxidative stress, and Zinc Concentration in Iraqi Women with Polycystic Ovary Syndrome. Rep Biochem Mol Biol. 2020;9(3):270\u20137.","journal-title":"Rep Biochem Mol Biol"},{"issue":"3","key":"1159_CR111","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2174\/187152808785748164","volume":"7","author":"A Hosseini-Tabatabaei","year":"2008","unstructured":"Hosseini-Tabatabaei A, Abdollahi M. Potassium channel openers and improvement of toxic stress: do they have role in the management of inflammatory bowel Disease? Inflamm Allergy Drug Targets. 2008;7(3):129\u201335.","journal-title":"Inflamm Allergy Drug Targets"},{"issue":"1","key":"1159_CR112","doi-asserted-by":"publisher","first-page":"9","DOI":"10.29252\/ijrm.14.1.9","volume":"14","author":"A Mahran","year":"2016","unstructured":"Mahran A, et al. Nitric oxide donors improve the ovulation and pregnancy rates in anovulatory women with polycystic ovary syndrome treated with clomiphene citrate: a RCT. Int J Reprod Biomed. 2016;14(1):9\u201314.","journal-title":"Int J Reprod Biomed"},{"issue":"8","key":"1159_CR113","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1093\/oxfordjournals.humrep.a136217","volume":"10","author":"H Kodama","year":"1995","unstructured":"Kodama H, et al. High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome. Hum Reprod. 1995;10(8):1962\u20137.","journal-title":"Hum Reprod"},{"issue":"8","key":"1159_CR114","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.kjms.2016.07.001","volume":"32","author":"N Akdemir","year":"2016","unstructured":"Akdemir N, et al. The correlation of serum asymmetric dimethylarginine and anti-M\u00fcllerian hormone in primary dysmenorrhea. Kaohsiung J Med Sci. 2016;32(8):414\u20139.","journal-title":"Kaohsiung J Med Sci"},{"key":"1159_CR115","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ejogrb.2015.05.005","volume":"191","author":"BN Hyderali","year":"2015","unstructured":"Hyderali BN, Mala K. Oxidative stress and cardiovascular Complications in polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol. 2015;191:15\u201322.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1159_CR116","doi-asserted-by":"publisher","first-page":"114593","DOI":"10.1016\/j.ecoenv.2023.114593","volume":"252","author":"XL Lai","year":"2023","unstructured":"Lai XL, et al. Zinc deficiency compromises the maturational competence of porcine oocyte by inducing mitophagy and apoptosis. Ecotoxicol Environ Saf. 2023;252:114593.","journal-title":"Ecotoxicol Environ Saf"},{"key":"1159_CR117","doi-asserted-by":"crossref","unstructured":"Khashchenko E et al. Activation of systemic inflammation and oxidative stress in adolescent girls with polycystic ovary syndrome in combination with metabolic disorders and excessive body weight. J Clin Med, 2020. 9(5).","DOI":"10.3390\/jcm9051399"},{"issue":"5","key":"1159_CR118","doi-asserted-by":"publisher","first-page":"E794","DOI":"10.1152\/ajpendo.00359.2018","volume":"316","author":"M Hu","year":"2019","unstructured":"Hu M, et al. Hyperandrogenism and insulin resistance induce gravid uterine defects in association with mitochondrial dysfunction and aberrant reactive oxygen species production. Am J Physiol Endocrinol Metab. 2019;316(5):E794\u2013E809.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"1159_CR119","doi-asserted-by":"publisher","first-page":"e000992","DOI":"10.1161\/JAHA.112.000992","volume":"1","author":"XF Ming","year":"2012","unstructured":"Ming XF, et al. Arginase II promotes macrophage inflammatory responses through mitochondrial reactive oxygen species, contributing to Insulin Resistance and Atherogenesis. J Am Heart Assoc. 2012;1(4):e000992.","journal-title":"J Am Heart Assoc"},{"issue":"12","key":"1159_CR120","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1093\/humrep\/deq257","volume":"25","author":"J B\u00f3dis","year":"2010","unstructured":"B\u00f3dis J, et al. Negative association of L-arginine methylation products with oocyte numbers. Hum Reprod. 2010;25(12):3095\u2013100.","journal-title":"Hum Reprod"},{"issue":"1","key":"1159_CR121","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jsmc.2007.11.001","volume":"3","author":"E Tasali","year":"2008","unstructured":"Tasali E, Van Cauter E, Ehrmann DA. Polycystic ovary syndrome and obstructive sleep apnea. Sleep Med Clin. 2008;3(1):37\u201346.","journal-title":"Sleep Med Clin"},{"issue":"13","key":"1159_CR122","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.steroids.2012.08.005","volume":"77","author":"YS Choi","year":"2012","unstructured":"Choi YS, et al. Serum asymmetric dimethylarginine, apelin, and Tumor necrosis factor-\u03b1 levels in non-obese women with polycystic ovary syndrome. Steroids. 2012;77(13):1352\u20138.","journal-title":"Steroids"},{"issue":"1","key":"1159_CR123","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1210\/jc.2007-0842","volume":"93","author":"D Heutling","year":"2008","unstructured":"Heutling D, et al. Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment. J Clin Endocrinol Metab. 2008;93(1):82\u201390.","journal-title":"J Clin Endocrinol Metab"},{"key":"1159_CR124","doi-asserted-by":"crossref","unstructured":"Rojas J et al. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth Int J Reprod Med, 2014. 2014: p.\u00a0719050.","DOI":"10.1155\/2014\/719050"},{"issue":"2","key":"1159_CR125","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1152\/physrev.00037.2016","volume":"98","author":"RW Caldwell","year":"2018","unstructured":"Caldwell RW, et al. Arginase: a multifaceted enzyme important in Health and Disease. Physiol Rev. 2018;98(2):641\u201365.","journal-title":"Physiol Rev"},{"issue":"2","key":"1159_CR126","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1006\/geno.1996.0606","volume":"38","author":"JG Vockley","year":"1996","unstructured":"Vockley JG, et al. Cloning and characterization of the human type II arginase gene. Genomics. 1996;38(2):118\u201323.","journal-title":"Genomics"},{"issue":"1","key":"1159_CR127","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0006-291X(86)80333-3","volume":"141","author":"GJ Dizikes","year":"1986","unstructured":"Dizikes GJ, et al. Isolation of human liver arginase cDNA and demonstration of nonhomology between the two human arginase genes. Biochem Biophys Res Commun. 1986;141(1):53\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"1159_CR128","doi-asserted-by":"publisher","first-page":"e12107","DOI":"10.1371\/journal.pone.0012107","volume":"5","author":"PO Gannon","year":"2010","unstructured":"Gannon PO, et al. Androgen-regulated expression of arginase 1, arginase 2 and interleukin-8 in human Prostate cancer. PLoS ONE. 2010;5(8):e12107.","journal-title":"PLoS ONE"},{"key":"1159_CR129","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.niox.2022.09.002","volume":"129","author":"TY Momma","year":"2022","unstructured":"Momma TY, Ottaviani JI. There is no direct competition between arginase and nitric oxide synthase for the common substrate l-arginine. Nitric Oxide. 2022;129:16\u201324.","journal-title":"Nitric Oxide"},{"issue":"5","key":"1159_CR130","doi-asserted-by":"publisher","first-page":"H651","DOI":"10.1152\/ajpheart.00755.2012","volume":"305","author":"S Elms","year":"2013","unstructured":"Elms S, et al. Insights into the arginine paradox: evidence against the importance of subcellular location of arginase and eNOS. Am J Physiol Heart Circ Physiol. 2013;305(5):H651\u201366.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1159_CR131","doi-asserted-by":"crossref","unstructured":"Wu G, Morris SM Jr. Arginine metabolism: nitric oxide and beyond Biochem J, 1998. 336 (Pt 1)(Pt 1): p.\u00a01\u201317.","DOI":"10.1042\/bj3360001"},{"key":"1159_CR132","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1741-7015-10-153","volume":"10","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, et al. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med. 2012;10:153.","journal-title":"BMC Med"},{"key":"1159_CR133","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.metabol.2018.10.008","volume":"90","author":"A Kyselova","year":"2019","unstructured":"Kyselova A, et al. Association between arginase-containing platelet-derived microparticles and altered plasma arginine metabolism in polycystic ovary syndrome. Metabolism. 2019;90:16\u20139.","journal-title":"Metabolism"},{"issue":"9","key":"1159_CR134","doi-asserted-by":"publisher","first-page":"4083","DOI":"10.1177\/0300060519864493","volume":"47","author":"C Meng","year":"2019","unstructured":"Meng C. Nitric oxide (NO) levels in patients with polycystic ovary syndrome (PCOS): a meta-analysis. J Int Med Res. 2019;47(9):4083\u201394.","journal-title":"J Int Med Res"},{"key":"1159_CR135","doi-asserted-by":"crossref","unstructured":"Pokorska-Niewiada K, Brodowska A, Szczuko M. The content of minerals in the PCOS Group and the correlation with the parameters of metabolism. Nutrients, 2021. 13(7).","DOI":"10.3390\/nu13072214"},{"issue":"2","key":"1159_CR136","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3164\/jcbn.15-87","volume":"58","author":"T Suzuki","year":"2016","unstructured":"Suzuki T, et al. Dietary zinc deficiency induces oxidative stress and promotes Tumor necrosis factor-alpha- and interleukin-1beta-induced RANKL expression in rat bone. J Clin Biochem Nutr. 2016;58(2):122\u20139.","journal-title":"J Clin Biochem Nutr"},{"issue":"2","key":"1159_CR137","first-page":"134","volume":"25","author":"FW Sunderman Jr","year":"1995","unstructured":"Sunderman FW Jr. The influence of zinc on apoptosis. Ann Clin Lab Sci. 1995;25(2):134\u201342.","journal-title":"Ann Clin Lab Sci"},{"issue":"5","key":"1159_CR138","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1093\/biolre\/ioab023","volume":"104","author":"TB Garner","year":"2021","unstructured":"Garner TB, et al. Role of zinc in female reproduction. Biol Reprod. 2021;104(5):976\u201394.","journal-title":"Biol Reprod"},{"key":"1159_CR139","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jtemb.2019.01.002","volume":"52","author":"M Abedini","year":"2019","unstructured":"Abedini M, et al. Zinc status and polycystic ovarian syndrome: a systematic review and meta-analysis. J Trace Elem Med Biol. 2019;52:216\u201321.","journal-title":"J Trace Elem Med Biol"},{"key":"1159_CR140","doi-asserted-by":"crossref","unstructured":"Nasiadek M et al. The role of zinc in selected female Reproductive System disorders. Nutrients, 2020. 12(8).","DOI":"10.3390\/nu12082464"},{"key":"1159_CR141","doi-asserted-by":"publisher","first-page":"572384","DOI":"10.3389\/fendo.2020.572384","volume":"11","author":"J Yin","year":"2020","unstructured":"Yin J, et al. Serum Trace Elements in patients with polycystic ovary syndrome: a systematic review and Meta-analysis. Front Endocrinol (Lausanne). 2020;11:572384.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"1159_CR142","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1172\/JCI0214442","volume":"109","author":"MH Zou","year":"2002","unstructured":"Zou MH, Shi C, Cohen RA. Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest. 2002;109(6):817\u201326.","journal-title":"J Clin Invest"},{"key":"1159_CR143","doi-asserted-by":"crossref","unstructured":"Fujii J, Homma T, Osaki T. Superoxide Radicals in the Execution of Cell Death Antioxidants (Basel), 2022. 11(3).","DOI":"10.3390\/antiox11030501"},{"issue":"8","key":"1159_CR144","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.bbadis.2006.06.011","volume":"1762","author":"S Mitra","year":"2006","unstructured":"Mitra S, Abraham E. Participation of superoxide in neutrophil activation and cytokine production. Biochim Biophys Acta. 2006;1762(8):732\u201341.","journal-title":"Biochim Biophys Acta"},{"key":"1159_CR145","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","volume":"5","author":"G Arango Duque","year":"2014","unstructured":"Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious Diseases. Front Immunol. 2014;5:491.","journal-title":"Front Immunol"},{"issue":"3","key":"1159_CR146","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4274\/tjod.galenos.2022.29498","volume":"19","author":"\u00d6 \u00d6zdemir Ba\u015fer","year":"2022","unstructured":"\u00d6zdemir Ba\u015fer \u00d6, G\u00f6\u00e7men AY, Aydo\u011fan D, K\u0131rm\u0131z\u0131. The role of inflammation, oxidation and Cystatin-C in the pathophysiology of polycystic ovary syndrome. Turk J Obstet Gynecol. 2022;19(3):229\u201335.","journal-title":"Turk J Obstet Gynecol"},{"key":"1159_CR147","doi-asserted-by":"crossref","unstructured":"Bizo\u0144 A et al. The activity of Superoxide dismutase, its relationship with the concentration of zinc and copper and the prevalence of rs2070424 superoxide dismutase gene in women with polycystic ovary syndrome-preliminary study. J Clin Med, 2022. 11(9).","DOI":"10.3390\/jcm11092548"},{"key":"1159_CR148","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1146\/annurev.biochem.72.121801.161647","volume":"74","author":"JS Valentine","year":"2005","unstructured":"Valentine JS, Doucette PA, Zittin S, Potter. Copper-zinc superoxide dismutase and Amyotrophic Lateral Sclerosis. Annu Rev Biochem. 2005;74:563\u201393.","journal-title":"Annu Rev Biochem"},{"issue":"1","key":"1159_CR149","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1432-1033.1980.tb06094.x","volume":"111","author":"H Nohl","year":"1980","unstructured":"Nohl H, Jordan W. The metabolic fate of mitochondrial hydrogen peroxide. Eur J Biochem. 1980;111(1):203\u201310.","journal-title":"Eur J Biochem"},{"issue":"4","key":"1159_CR150","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0891-5849(00)00486-X","volume":"30","author":"TD Oberley","year":"2001","unstructured":"Oberley TD, et al. Localization of the thioredoxin system in normal rat kidney. Free Radic Biol Med. 2001;30(4):412\u201324.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1159_CR151","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1006\/abbi.1997.9901","volume":"340","author":"RS Esworthy","year":"1997","unstructured":"Esworthy RS, Ho YS, Chu FF. The Gpx1 gene encodes mitochondrial glutathione peroxidase in the mouse liver. Arch Biochem Biophys. 1997;340(1):59\u201363.","journal-title":"Arch Biochem Biophys"},{"issue":"22","key":"1159_CR152","doi-asserted-by":"publisher","first-page":"6049","DOI":"10.1016\/S0021-9258(18)63504-5","volume":"244","author":"JM McCord","year":"1969","unstructured":"McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244(22):6049\u201355.","journal-title":"J Biol Chem"},{"issue":"1","key":"1159_CR153","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.molcel.2013.08.038","volume":"52","author":"K Homma","year":"2013","unstructured":"Homma K, et al. SOD1 as a molecular switch for initiating the homeostatic ER stress response under zinc deficiency. Mol Cell. 2013;52(1):75\u201386.","journal-title":"Mol Cell"},{"issue":"14","key":"1159_CR154","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.1073\/pnas.94.14.7606","volume":"94","author":"LI Bruijn","year":"1997","unstructured":"Bruijn LI, et al. Elevated free nitrotyrosine levels, but not protein-bound nitrotyrosine or hydroxyl radicals, throughout Amyotrophic Lateral Sclerosis (ALS)-like Disease implicate tyrosine nitration as an aberrant in vivo property of one familial ALS-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci U S A. 1997;94(14):7606\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1159_CR155","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/ajcn\/61.6.1263","volume":"61","author":"KL Olin","year":"1995","unstructured":"Olin KL, et al. Extracellular superoxide dismutase activity is affected by dietary zinc intake in nonhuman primate and rodent models. Am J Clin Nutr. 1995;61(6):1263\u20137.","journal-title":"Am J Clin Nutr"},{"key":"1159_CR156","doi-asserted-by":"crossref","unstructured":"Di Marzo N, Chisci E, Giovannoni R. The role of Hydrogen Peroxide in Redox-Dependent Signaling: homeostatic and pathological responses in mammalian cells. Cells, 2018. 7(10).","DOI":"10.3390\/cells7100156"},{"issue":"12","key":"1159_CR157","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1351\/pac200779122325","volume":"79","author":"J Prousek","year":"2007","unstructured":"Prousek J. Fenton chemistry in biology and medicine. Pure Appl Chem. 2007;79(12):2325\u201338.","journal-title":"Pure Appl Chem"},{"issue":"3","key":"1159_CR158","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1600-0412.2011.01337.x","volume":"91","author":"G Baskol","year":"2012","unstructured":"Baskol G, et al. Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2012;91(3):326\u201330.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"1159_CR159","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0009-9120(01)00245-4","volume":"34","author":"T Sabuncu","year":"2001","unstructured":"Sabuncu T, et al. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of Cardiovascular Disease. Clin Biochem. 2001;34(5):407\u201313.","journal-title":"Clin Biochem"},{"issue":"4","key":"1159_CR160","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10815-014-0190-7","volume":"31","author":"AK Seleem","year":"2014","unstructured":"Seleem AK, et al. Superoxide dismutase in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection. J Assist Reprod Genet. 2014;31(4):499\u2013504.","journal-title":"J Assist Reprod Genet"},{"key":"1159_CR161","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2147\/IJWH.S345853","volume":"14","author":"X Cheng","year":"2022","unstructured":"Cheng X, He B. Clinical and biochemical potential of antioxidants in treating polycystic ovary syndrome. Int J Womens Health. 2022;14:467\u201379.","journal-title":"Int J Womens Health"},{"issue":"32","key":"1159_CR162","doi-asserted-by":"publisher","first-page":"e30006","DOI":"10.1097\/MD.0000000000030006","volume":"101","author":"J Zhao","year":"2022","unstructured":"Zhao J, et al. Effects of antioxidant intervention in patients with polycystic ovarian syndrome: a systematic review and meta-analysis. Med (Baltim). 2022;101(32):e30006.","journal-title":"Med (Baltim)"},{"issue":"1","key":"1159_CR163","first-page":"1","volume":"13","author":"L Amini","year":"2015","unstructured":"Amini L, et al. Antioxidants and management of polycystic ovary syndrome in Iran: a systematic review of clinical trials. Iran J Reprod Med. 2015;13(1):1\u20138.","journal-title":"Iran J Reprod Med"},{"key":"1159_CR164","doi-asserted-by":"publisher","first-page":"106180","DOI":"10.1016\/j.jsbmb.2022.106180","volume":"225","author":"T Li","year":"2023","unstructured":"Li T, et al. The ADMA-DDAH1 axis in ovarian apoptosis of polycystic ovary syndrome. J Steroid Biochem Mol Biol. 2023;225:106180.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"1159_CR165","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0008-6363(99)00115-7","volume":"43","author":"PJ Andrew","year":"1999","unstructured":"Andrew PJ, Mayer B. Enzymatic function of nitric oxide synthases. Cardiovasc Res. 1999;43(3):521\u201331.","journal-title":"Cardiovasc Res"},{"issue":"7","key":"1159_CR166","doi-asserted-by":"publisher","first-page":"837a","DOI":"10.1093\/eurheartj\/ehr304","volume":"33","author":"U Forstermann","year":"2012","unstructured":"Forstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J. 2012;33(7):837a\u2013837d. 829 \u2013 37.","journal-title":"Eur Heart J"},{"issue":"7","key":"1159_CR167","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.freeradbiomed.2007.11.014","volume":"44","author":"AP Goud","year":"2008","unstructured":"Goud AP, et al. Reactive oxygen species and oocyte aging: role of superoxide, hydrogen peroxide, and hypochlorous acid. Free Radic Biol Med. 2008;44(7):1295\u2013304.","journal-title":"Free Radic Biol Med"},{"key":"1159_CR168","doi-asserted-by":"crossref","unstructured":"Khan AA, Alsahli MA, Rahmani AH. Myeloperoxidase as an active Disease Biomarker: recent biochemical and pathological perspectives. Med Sci (Basel), 2018. 6(2).","DOI":"10.3390\/medsci6020033"},{"key":"1159_CR169","unstructured":"Varela CD, Farhana A. Biochemistry, Superoxides, in StatPearls. 2023: Treasure Island (FL) ineligible companies. Disclosure: Aisha Farhana declares no relevant financial relationships with ineligible companies."},{"key":"1159_CR170","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.freeradbiomed.2012.12.007","volume":"58","author":"F Shaeib","year":"2013","unstructured":"Shaeib F, et al. Impact of hydrogen peroxide-driven Fenton reaction on mouse oocyte quality. Free Radic Biol Med. 2013;58:154\u20139.","journal-title":"Free Radic Biol Med"},{"issue":"8","key":"1159_CR171","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/S0009-9120(99)00075-2","volume":"32","author":"JM Mates","year":"1999","unstructured":"Mates JM, Perez-Gomez C. Nunez De Castro, antioxidant enzymes and human Diseases. Clin Biochem. 1999;32(8):595\u2013603.","journal-title":"Clin Biochem"},{"key":"1159_CR172","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ejogrb.2018.06.007","volume":"228","author":"AM Sylus","year":"2018","unstructured":"Sylus AM, et al. Clomiphene citrate increases nitric oxide, interleukin-10 and reduces matrix metalloproteinase-9 in women with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2018;228:27\u201331.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"1159_CR173","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1055\/s-0035-1548929","volume":"123","author":"S Tepav\u010devi\u0107","year":"2015","unstructured":"Tepav\u010devi\u0107 S, et al. Cardiac nitric oxide synthases and Na+\/K+-ATPase in the Rat Model of Polycystic Ovary Syndrome Induced by Dihydrotestosterone. Exp Clin Endocrinol Diabetes. 2015;123(5):303\u20137.","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"13","key":"1159_CR174","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1111\/1471-0528.12834","volume":"121","author":"GR Willis","year":"2014","unstructured":"Willis GR, et al. Detailed characterisation of circulatory nitric oxide and free radical indices\u2013is there evidence for abnormal cardiovascular homeostasis in young women with polycystic ovary syndrome? BJOG. 2014;121(13):1596\u2013603.","journal-title":"BJOG"},{"issue":"3","key":"1159_CR175","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.maturitas.2008.08.003","volume":"61","author":"K Walch","year":"2008","unstructured":"Walch K, Kolbus A, Hefler-Frischmuth K. Polymorphisms of the endothelial nitric oxide synthase gene in premenopausal women with polycystic ovary syndrome. Maturitas. 2008;61(3):256\u20139.","journal-title":"Maturitas"},{"issue":"2","key":"1159_CR176","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ejogrb.2006.09.009","volume":"133","author":"AP N\u00e1cul","year":"2007","unstructured":"N\u00e1cul AP, et al. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity. Eur J Obstet Gynecol Reprod Biol. 2007;133(2):191\u20136.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1159_CR177","doi-asserted-by":"publisher","first-page":"1211231","DOI":"10.3389\/fimmu.2023.1211231","volume":"14","author":"G Bat\u00f3g","year":"2023","unstructured":"Bat\u00f3g G, et al. The interplay of oxidative stress and immune dysfunction in Hashimoto\u2019s thyroiditis and polycystic ovary syndrome: a comprehensive review. Front Immunol. 2023;14:1211231.","journal-title":"Front Immunol"},{"key":"1159_CR178","doi-asserted-by":"crossref","unstructured":"Srnovr\u0161nik T, Virant-Klun I, Pinter B. Heavy Metals and Essential Elements in Association with oxidative stress in women with polycystic ovary Syndrome-A systematic review. Antioxid (Basel), 2023. 12(7).","DOI":"10.3390\/antiox12071398"},{"issue":"8","key":"1159_CR179","doi-asserted-by":"publisher","first-page":"8991","DOI":"10.21037\/apm-21-2018","volume":"10","author":"J Yuan","year":"2021","unstructured":"Yuan J, Wen X, Jia M. Efficacy of omega-3 polyunsaturated fatty acids on hormones, oxidative stress, and inflammatory parameters among polycystic ovary syndrome: a systematic review and meta-analysis. Ann Palliat Med. 2021;10(8):8991\u20139001.","journal-title":"Ann Palliat Med"},{"issue":"6","key":"1159_CR180","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1017\/S0007114520003207","volume":"125","author":"JAG Tosatti","year":"2021","unstructured":"Tosatti JAG, et al. Influence of n-3 fatty acid supplementation on inflammatory and oxidative stress markers in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Br J Nutr. 2021;125(6):657\u201368.","journal-title":"Br J Nutr"},{"issue":"1","key":"1159_CR181","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12602-019-09559-0","volume":"14","author":"R Tabrizi","year":"2022","unstructured":"Tabrizi R, et al. The effects of Probiotic supplementation on clinical Symptom, Weight loss, Glycemic Control, lipid and hormonal profiles, biomarkers of inflammation, and oxidative stress in women with polycystic ovary syndrome: a systematic review and Meta-analysis of Randomized controlled trials. Probiotics Antimicrob Proteins. 2022;14(1):1\u201314.","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"4","key":"1159_CR182","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1055\/s-0044-101355","volume":"50","author":"M Akbari","year":"2018","unstructured":"Akbari M, et al. The effects of vitamin D supplementation on biomarkers of inflammation and oxidative stress among women with polycystic ovary syndrome: a systematic review and Meta-analysis of Randomized controlled trials. Horm Metab Res. 2018;50(4):271\u20139.","journal-title":"Horm Metab Res"},{"issue":"3","key":"1159_CR183","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/humupd\/dms059","volume":"19","author":"M Murri","year":"2013","unstructured":"Murri M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013;19(3):268\u201388.","journal-title":"Hum Reprod Update"},{"key":"1159_CR184","doi-asserted-by":"crossref","unstructured":"Kaltsas A et al. The Silent Threat to Women\u2019s Fertility: Uncovering the Devastating Effects of Oxidative Stress. Antioxid (Basel), 2023. 12(8).","DOI":"10.3390\/antiox12081490"},{"issue":"4","key":"1159_CR185","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1017\/S0967199420000179","volume":"28","author":"M Jamil","year":"2020","unstructured":"Jamil M, et al. Reactive oxygen species in reproduction: harmful, essential or both? Zygote. 2020;28(4):255\u201369.","journal-title":"Zygote"},{"issue":"3","key":"1159_CR186","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/GCO.0000000000000619","volume":"32","author":"M Cozzolino","year":"2020","unstructured":"Cozzolino M, Seli E. Mitochondrial function in women with polycystic ovary syndrome. Curr Opin Obstet Gynecol. 2020;32(3):205\u201312.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"1159_CR187","doi-asserted-by":"crossref","unstructured":"Jiang Y et al. Applications of Melatonin in Female Reproduction in the Context of Oxidative Stress Oxid Med Cell Longev, 2021. 2021: p.\u00a06668365.","DOI":"10.1155\/2021\/6668365"},{"issue":"12","key":"1159_CR188","doi-asserted-by":"publisher","first-page":"7966","DOI":"10.1002\/jcp.30468","volume":"236","author":"L Wang","year":"2021","unstructured":"Wang L, et al. Oxidative stress in oocyte aging and female reproduction. J Cell Physiol. 2021;236(12):7966\u201383.","journal-title":"J Cell Physiol"},{"issue":"2","key":"1159_CR189","doi-asserted-by":"publisher","first-page":"e13265","DOI":"10.1111\/aji.13265","volume":"84","author":"Z Yang","year":"2020","unstructured":"Yang Z, et al. Controlling chronic low-grade inflammation to improve follicle development and survival. Am J Reprod Immunol. 2020;84(2):e13265.","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"1159_CR190","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12958-018-0391-5","volume":"16","author":"J Lu","year":"2018","unstructured":"Lu J, et al. A novel and compact review on the role of oxidative stress in female reproduction. Reprod Biol Endocrinol. 2018;16(1):80.","journal-title":"Reprod Biol Endocrinol"},{"issue":"2","key":"1159_CR191","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1017\/S0954422418000136","volume":"31","author":"L Barrea","year":"2018","unstructured":"Barrea L, et al. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome. Nutr Res Rev. 2018;31(2):291\u2013301.","journal-title":"Nutr Res Rev"},{"key":"1159_CR192","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biopha.2018.04.003","volume":"103","author":"AK Pandey","year":"2018","unstructured":"Pandey AK, et al. Impact of stress on female reproductive health disorders: possible beneficial effects of shatavari (Asparagus racemosus). Biomed Pharmacother. 2018;103:46\u20139.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"1159_CR193","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1177\/1933719116674077","volume":"23","author":"J \u00c1vila","year":"2016","unstructured":"\u00c1vila J, et al. Oxidative stress in Granulosa-Lutein cells from in Vitro Fertilization patients. Reprod Sci. 2016;23(12):1656\u201361.","journal-title":"Reprod Sci"},{"key":"1159_CR194","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1477-7827-10-49","volume":"10","author":"A Agarwal","year":"2012","unstructured":"Agarwal A, et al. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012;10:49.","journal-title":"Reprod Biol Endocrinol"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-023-01159-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-023-01159-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-023-01159-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T02:03:56Z","timestamp":1700705036000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-023-01159-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,23]]},"references-count":194,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1159"],"URL":"https:\/\/doi.org\/10.1186\/s12958-023-01159-6","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,23]]},"assertion":[{"value":"6 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}